Drug Type Synthetic peptide |
Synonyms CBLB 612 |
Target |
Mechanism TLR2 agonists(Toll like receptor 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC77H135N13O24S |
InChIKeyJJPFGYKSHVVRDE-LXCBNONTSA-N |
CAS Registry1039381-80-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 2 | - | 01 Dec 2015 | |
Neutropenia | Phase 2 | - | 01 Dec 2015 | |
Hematopoietic stem cell transplantation | Phase 2 | - | - | |
Hematopoietic stem cell transplantation | Phase 2 | - | - |